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The Covid-19 pandemic necessitated a rapid global transition towards telemedicine; yet much 
remains unknown about telemedicine’s acceptability and safety in rheumatology. To help address 
this gap and inform practice, this study investigated rheumatology patient and clinician experiences 
and views of telemedicine.
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Sequential mixed methodology combined analysis of surveys and in-depth interviews. Between and 
within-group differences in views of telemedicine were examined for patients and clinicians using t-
tests.
Results
Surveys (Patients n=1,340, Clinicians n=111) and interviews (Patients n= 31, Clinicians n=29) were 
completed between April 2021 and July 2021. The majority of patients were from the UK (96%) and 
had inflammatory arthritis (32%) or lupus (32%). Patients and clinicians rated telemedicine as worse 
than face-to-face consultations in almost all categories, although >60% found it more convenient. 
Building trusting medical relationships and assessment accuracy were great concerns (93% of 
clinicians and 86% of patients rated telemedicine as worse than face-to-face for assessment 
accuracy). Telemedicine was perceived to have increased misdiagnoses, inequalities and barriers to 
accessing care. Participants reported highly disparate telemedicine delivery and responsiveness from 
primary and secondary care. Although rheumatology clinicians highlighted the importance of a quick 
response to flaring patients, only 55% of patients were confident that their rheumatology 
department would respond within 48 hours.
Conclusion
Findings indicate a preference for face-to-face consultations. Some negative experiences may be due 
to the pandemic rather than telemedicine specifically, although the risk of greater diagnostic 
inaccuracies using telemedicine is unlikely to be fully resolved.  Training, choice, careful patient 
selection, and further consultation with clinicians and patients is required to increase telemedicine’s 
acceptability and safety. 









































































1. Concerns about telemedicine included: reduced assessment accuracy; impaired medical- 
relationship building; and increased inequalities for vulnerable and/or disadvantaged patients.  
2. Barriers to patient-initiated contact, including ‘gate-keeping’ administrators and non-
response, are limiting emergency access.
3. Telemedicine is convenient and acceptable for some rheumatology patients. Careful 
selection and choice are key.
Key words: Telemedicine, rheumatology, patient-physician interactions, digital technology in 
medicine, pandemic, mixed-methods, rare autoimmune rheumatic diseases
Introduction 
The Covid-19 pandemic necessitated a rapid reorganisation of patient care to predominantly 
telemedicine in the UK1 and elsewhere2,3,4. This trend seems set to continue5, with support from 
governments and health-services6.  NHS England’s 2021/2022 planning guidance, for example, states 
that at least 25% of outpatient appointments should be by telephone or video6. However, 
telemedicine’s suitability, acceptability and safety in rheumatology has yet to be ascertained. The 
majority of rheumatology studies have focused on rheumatoid arthritis, and there is limited 
evidence relating to the rare autoimmune rheumatic diseases7,8 such as lupus or systemic sclerosis, 
which can have life-threatening9, yet less visible10 manifestations.
McDougal et al’s tele-rheumatology systematic review found that most studies reviewed 
‘demonstrated a high risk of bias’11; and studies have produced conflicting results. Some report high 
levels of patient satisfaction12,13 and suggest that telemedicine could be as effective as face-to-face 
for autoimmune rheumatic diseases14. However, there are concerns regarding the use of 








































































telemedicine for diagnosis and assessment of disease activity15, particularly as a result of lack of 
physical examinations16. Studies to date have tended to be limited by sample size14, only reporting 
the views of one side of the medical relationship and/or only including patients from the 
investigators’ hospital13,17, which could increase the risk of bias. 
The pandemic-initiated extensive use of telemedicine has highlighted the need for detailed research 
ahead of more permanent digital service delivery. Our study therefore elicited the views and 
experiences of clinicians, and patients with a wide range of inflammatory rheumatic diseases. 
Methods
Participants and design
A pre-tested survey for rheumatology patients was made available online in April 2021 using 
Qualtrics, via multiple disease support groups. A similar online survey for rheumatology clinicians 
was disseminated through rheumatology networks, including the British Society for Rheumatology, 
in May/June 2021. This telemedicine sub-study is part of a pre-registered longitudinal multi-stage 
trial (ISRCTN-14966097, including a statistical analysis plan with Covid-related additions registered 
March 2021). Ethical approval was obtained through the Cambridge Psychology Research 
Committee. Respondents gave informed written (electronic) consent on the survey and/or verbally 
recorded consent prior to interviews.
Inclusion criteria: Patients: age ≥18 years, reporting a diagnosis of an autoimmune inflammatory 
rheumatological condition on their clinic letters and having received at least one telemedicine 
appointment. Clinicians: UK-based clinicians involved in the care of rheumatology patients (including 
consultants, registrars, specialist nurses and General Practitioners (GPs)).
Questions elicited demographic, and quantitative (predominately using Likert scales comparing 
telemedicine with face-to-face (F2F)) and qualitative responses about telemedicine views and 








































































experiences. Medical security was measured on a scale of 0-100 with 0 signifying ‘completely 
medically abandoned’ to 100 signifying ‘completely medical secure’. Interviewees were largely 
purposively selected from the questionnaires to ensure a range of characteristics and views. 
Interviews were semi-structured, continued until thematic saturation was reached and were 
conducted by M.S, an experienced, qualitatively-trained researcher. Interviews lasted for 0.5-3 hours 
and were transcribed verbatim. 
Analysis
This study used multi-stage sequential mixed methods. Interview data was collected both before 
survey design to ascertain patient and clinician priorities for research directions, and also after initial 
analysis (using SPSS v.26) of quantitative data to further explore and explain quantitative findings. 
Both types of data were given equal priority and the use of mixed methods reduced the inherent 
weaknesses in each individual method. Mean differences between patients and clinicians, and 
within-groups differences, were tested for statistical significance using t-tests. Pearson’s or 
Spearman’s rank were used for correlations as appropriate. Thematic analysis18 was used for the 
interviews and the qualitative data from the surveys, using NVivo12 to assist in managing and coding 
the qualitative data. The coding frame was developed by MS, RH and MB, with coding agreed by FN, 
EL, PH and CG, to improve reliability. Emerging themes were discussed and agreed by the wider 
team, including patient representatives and clinicians. Validity was strengthened by triangulation of 
quantitative and qualitative results19, which were combined at all stages from planning through 
analysis to reporting, consideration of cases that deviated from the emerging conclusions20 and 
member checking21. The criteria for reporting qualitative research (COREQ)22, detailed methodology 
and limitations are included in Supplementary Data S1, available at Rheumatology online. Further 
statistical analysis is available in Supplementary Data S2, available at Rheumatology online. 








































































Ethical Approval: Ethical approval was obtained through the Cambridge Psychology Research 
Committee: PRE.2019.099: approval for original trial; PRE.2020.089: approval for COVID-19 related 
additions and amendments.
Trial registration: This telemedicine study is part of a pre-registered longitudinal multi-stage trial, 
the LISTEN study (ISRCTN-14966097), with later Covid-related additions registered in March 2021, 
including a pre-registered statistical analysis plan.
Results 
A total of 1,340 patients and 111 clinicians completed the surveys; 60 (31 patients and 29 clinicians) 
were interviewed (table 1). The four most commonly reported rheumatological diseases were 
inflammatory arthritis (32%), lupus (32%), Sjogren’s (9%), and systemic sclerosis (8%). The survey 
was open to clinicians working in the UK and patients of any nationality, but patient respondents 
were largely from the UK (96%). Numerical values given are from survey quantitative data. Within 
text quotes were not given participant numbers if the term used was given by multiple participants.
Table 1. Participant characteristics









<30 222 (17%) 4 (13%) 5 (5%) 0
30-39 247 (18%) 3 (10%) 19 (17%) 9 (31%)
40-49 406 (30%) 8 (26%) 39 (35%) 5 (17%)
50-59 308 (23%) 9  (29%) 37 (33%) 11 (38%)
60+ 155 (12%) 7 (23%) 11 (10%) 4 (14%)
Gender
Female 1275 (95%) 27 (87%) 77 (69%) 11 (38%)
Male 59 (4%) 4 (13%) 34 (31%) 18 (62%)
Other/undisclosed 6 (<1%) 0 0 0
Country/region 
England 1060 (79%) 17 (55%) 87 (78%) 24 (83%)
Scotland 112 (8%) 4 (13%) 13 (11%) 2 (7%)
Wales 68 (5%) 8 (26%) 9 (8%) 1 (3%)
N. Ireland 36 (3%) 0 2 (2%) 2 (7%)
US/Canada 30 (2%) 1 (3%) 0 0








































































Europe 16 (1%) 1 (3%) 0 0





424 (32%) 7 (23%)
Lupus 419 (32%) 12 (39%)
Sjögrens 119 (9%) 2 (6%)
Systemic sclerosis 100 (8%) 3 (10%)
Vasculitis 47 (4%) 1 (3%)
UCTD 45 (3%) 3 (10%)
PMR 44 (3%) 2 (6%)
MCTD or two or 
more inflammatory 
rheumatic diseases




Time since diagnosis 
< 1 year 80 (6%) 3 (10%)
1-2 years 166 (12%) 5 (16%)
3-5 years 268 (20%) 5 (16%)
6-9 years 253 (19%) 9 (29%)
10+ years 568 (42%) 9 (29%)




72 (65%) 13 (45%)
Rheumatology 
registrar 
13 (12%) 5 (17%)
Rheumatology nurse 19 (17%) 5 (17%)
GP 0 (not surveyed) 5 (17%)
Other speciality 7(6%) 1(7%)
Five main telemedicine themes were identified: 1) Effect on the patient-clinician relationship; 2) 
Greater risk of inaccurate assessments; 3) Convenience, technology and logistical considerations; 4) 
Barriers to safe and effective telemedicine; and 5) Cost-cutting, clinical need or choice?
Theme 1: Effect on the patient-clinician relationship 
Significantly more (p=0.02) clinicians (90%) than patients (69%) felt that telemedicine was worse 
than face-to-face for building a trusting relationship (Figure 1a). The majority of clinicians discussed 
how non-verbal communication, including ‘reassuring’ touch, was important in building trust and/or 
rapport. Many patients used terminology - such as feeling like ‘a statistic’ or ‘uncared for’ - indicative 
of finding telemedicine more impersonal than in-person consultations. However, a substantial 








































































number of participants reported that positive relationships continued with telemedicine; and well-
established medical relationships were felt to be protective against the limitations of remote 
appointments.
Around 50% of clinicians and patients rated clinicians listening as worse with telemedicine, and 
<10% rated it better than with face-to-face.  Many patients felt telemedicine followed an impersonal 
‘tick list’ and felt more ‘rushed’. Patients’ ratings for telemedicine were significantly lower (mean 
difference, 0.49, p<0.001) than clinicians for time available to discuss patient concerns (Fig 3a), and 
many reported telephone consultations lasting <5 minutes. Other patients expressed 
disappointment regarding changes in their clinician’s behaviour using telemedicine:
The doctor, who is normally quite sympathetic, seemed very cold…very perfunctory and I felt he 
sounded rather irritated. I didn't feel very cared for at the end of the call, despite getting the outcome 
I felt I needed (patient 56, RA)
Some clinicians surmised that pandemic-induced backlogs might be temporarily reducing time 
available and patience during discussions, whilst others felt that telemedicine itself hindered 
displaying empathy or their ability to focus on the patient:
When I am in clinic I am 100% focused on the patient I have in front of me…but on the telephone I 
really struggle... we have less time. I am always watching the watch, I feel much more tired than with 
face to face (Clinician 23, Consultant)
Theme 2: Greater risk of inaccurate assessments








































































Patients (86%) and clinicians (93%) felt that telemedicine was worse than face-to-face in terms of 
accuracy of assessment (Fig 1b). Misdiagnoses and other inaccuracies were frequently reported and 
often attributed to the absence of examinations and visual cues:
My rheumatologist cannot see/hear how I move, look at my skin, eyes, hair, hands, bones, how I 
am…I was diagnosed with something over the phone, which I know isn’t right, and it’s getting worse 
(Patient 293, UCTD)
Compounding these problems was the cancelling of tests that could aid diagnoses. Patients reported 
having at least one blood (40% of patients) and/or other (48%) test (e.g. imaging) cancelled between 
March 2020 and March 2021. During that time, routine medication monitoring was restricted to 
protect patients from Covid-19 infection, but it remains limited, often due to continuing 
disagreements between primary and secondary care as to responsibility for testing when patients 
are being reviewed remotely: 
Secondary care has gone to much more telephone and requesting that GPs do the blood tests…I’m 
not sure what that abnormal result means, it feels like we’re doing secondary care’s job for them. It is 
less safe for the patient (Clinician 29, GP)
The risk of diagnostic errors from lack of examinations and tests was further increased by frequent 
under-playing of symptom severity by rheumatology patients. Willingness to report symptoms, 
including mental health (MH) symptoms, was reported as worse/much worse with telemedicine by 
approximately 45% of patients and clinicians. Clinicians also found it more difficult to identify MH 
concerns remotely:    








































































I can tell from somebody’s affect and demeanour, and how they look and how they’re different from 
how they’ve been previously and how they respond, you know those biological features of depression 
that I just can’t gauge over the phone (Clinician 10, Consultant)
A minority of patients and clinicians felt that telemedicine was better than face-to-face for 
remembering discussion points (16% of patients, 18% of clinicians), and for comfort with symptom-
reporting (12% of patients, 10% of clinicians); including, in some cases, for more personal symptoms 
and MH concerns: 
My largely invisible CTDs are easier to speak about to strangers over the phone - especially where it 
comes to intimate problems and mental wellbeing, or lack of. I feel I’m clearer by phone and less 
stressed out than I am by clinical environments (Patient 46, mixed/multiple) 
Further participant quotes on advantages and disadvantages of telemedicine are reported in table 2. 
Figure 1 -Views of telemedicine compared to F2F – medical relationships and assessment accuracy
0 10 20 30 40 50 60 70 80 90 100
Patients' anxiety - Clinician                                                                               
(MD = -0.47, P<0.001)
Patients' anxiety - Patient view
Clinicians' listening - Clinician view                                                                           
(MD = -0.17, P=0.04)
Clinicians' listening - Patient view
Building a trusting relationship - Clinician view                                                                                      
(MD = 0.19, P=0.02)
Buidling a trusting relationship - Patient view
Much worse Worse Same as F2F Better Much better
Fig 1a -Views on telemedicine compared to face to face - Relationship building and appointment anxiety 
(N=1,340 patients, N=111 clinicians)








































































0 10 20 30 40 50 60 70 80 90 100
Patients' remembering what to report- Clinician view                                                        
(MD = -0.33, P=0.001)
Patients' remembering what to report- Patient view
Symptom reporting - Clinician view                                                                      
(MD = -0.09, Non significant difference)
Symptom reporting - Patient view
Reporting MH concerns - Clinician view                                                                           
(MD = -0.02, Non significant difference)
Reporting MH concerns - Patient view
Accuracy of assessment - Clinician view                                                              
(MD = 0.04, Non-significant difference)
Accuracy of assessment - Patient view
Much worse Worse Same as F2F Better Much better
Fig 1b - Views on telemedicine compared to face to face - accuracy of diagnoses and symptom-reporting 
(N=1,340 patients, N=111 clinicians)
Note: T-tests comparing means of ratings from 1 (much worse) to 5 (much better) from clinicians and patients 
regarding views of telemedicine compared to F2F. MD = mean difference between scores of patients and 
clinicians assessed by t test.  If P>0.05 it is reported as non-significant.
Table 2. Illustrative participant quotes on the advantages and disadvantages of telemedicine




It's nice that my GP has called me. This way I 
didn't have to go to her Practice. She has also 
called me to check if I'm having flares. Small 
things like this really kept me going during 
lockdown (Patient 1063, lupus)
It’s definitely harder to build trust over the phone, 
and you’re picking up that they’re not saying 
everything, so much of that for me on my side is 
that I use very open body language, eye contact, 







Medics listened to symptoms because they 
couldn't see me. More so than in person. 
(Patient 517, Sjögrens)
All the time he was interrupting and my words 
were falling on deaf ears… ‘How's your skin?’ Me, 
‘starting to flare’. Again no advice or reaction… I 
felt like I was on a very long patient list he had to 
get through and he was taking no prisoners. I 
decided I didn't want to see him again and was 







I get huge anxiety just walking into the 
doctor's office because I feel like I'm not 
going to be heard. Also, I've had so many bad 
experiences, I don't feel like doctors are 
interested enough. So, in that regard, 
It is always different on the phone whereas if you 
see them you can see how they’re actually 
feeling…often feel like I’m not being 
believed…makes me report it less on the phone 
definitely. (Patient 80, lupus)










































































telemedicine is awesome. I'm in my home, on 




No advantages in this category specified by 
clinicians or patients
Telemedicine sucks and kills people. Might be 
good for administrative stuff, like questions 
about medications etc but dangerous for if you 
are actually unwell. Easy to dismiss a patient over 
the phone and impossible to physically exam 
them. And idiotic to make the patient and their 






I like them…honestly I feel more listened to 
and less dismissed…. Maybe it's changed how 
I present myself too as I'm more confident in 
my own space and not so aware of being 
judged visually (Patient 890, Systemic 
sclerosis)
It's quite easy to hide how you're really feeling. 
I've done this when my anxiety was having a 
wobble…needed more support than I let on. It's 
much easier to put a brave face on when on a 




It's helpful being able to make notes before 
and during the appointment when it's by 
phone.. so you don't forget to ask about all 
pertinent issues… I don't feel confident doing 
that in a face-to-face appointment. I think 
doctors hate it when you produce a list at an 
appointment (Patient 310, RA)
It’s harder for them to remember… they’re 
thinking about what’s going on in the 
background and in the house. They don’t actually 
then think so much and focus than if they were 
sitting in your office and there were no 
distractions…And they are not then as mentally 
prepared (Clinician 5, GP)
Convenience We are a tertiary centre and most of our 
patients travel for hours to get to us and it 
does seem bonkers at times when they do 
that and stay for 5 minutes...clearly a role for 
patients like that and I know a lot of them 
have really liked it. (Clinician 11, Registrar)
If we knew a time slot it would really improve 
telemedicine. I'm a teacher and can't take a call 
in class (Patient 1385, vasculitis)
Theme 3: Convenience, technology and logistical considerations
Over 60% of patients and clinicians considered telemedicine more convenient than face-to-face 
(Figure 2), often citing safety from infection, no travelling, and reduced waiting times, as the main 
advantages (Table 3a): 
I am very glad that telemedicine has become an option as it not only makes me feel more relaxed 
and safer, but I often have great difficulty getting to hospital (Patient 635, lupus)
Clinicians significantly over-estimated the convenience for patients compared with patient views 
(mean clinician rating of 3.86, mean patient rating of 3.49, mean difference=0.37, p=0.001), and 
many patients reported that they weren’t given appointment times for telemedicine in the same 
way as for face-to-face, leading to greater inconvenience for some. In addition, remote 
appointments did not always save clinicians’ time (Fig. 2b). Telemedicine involves more 








































































administration, including sending blood forms and prescriptions that would have been handed to the 
patient in a face-to-face appointment. Patients were often ‘double-seen’ by clinicians who arranged 
a face-to-face appointment for any they were concerned about. Administrative errors meant that 
patients were sometimes not informed as to whether their appointment was face-to-face or 
telemedicine. Although some clinicians reported an improved work-life balance through remote-
working, others found their workload expanding as a result of the increase in direct patient 
communication (such as by email).
NHS technology and organisation were sometimes spoken of in strongly negative terms, such as 
being ‘embarrassingly primitive’ (Clinician 82, Consultant); although several clinicians reported rapid 
pandemic-induced improvements in technology. Despite sometimes ‘fierce opposition’ (Clinician 4, 
Consultant) to change initially from some clinicians, hospitals with existing integrated technology for 
communication between clinicians and patients had an easier transition to telemedicine and greater 
patient satisfaction:
The addition of the "MyChart" app…has really helped me. I can send a message without battling to 
pick up the phone, I can attach photos which can then be shown to my rheumatologist, and I receive 
all my blood test results quickly too (Patient 825, mixed/multiple)
Clinicians and patients felt that the medical relationship and the quality of care would benefit from 
improved telemedicine skills for patients: once my daughter had taught me how to email photos I 
sent some flare pictures in (Patient 1424, Sjogren’s), and also for clinicians:
I have taught telemedicine myself as a clinical subject. What is apparent in the current situation is 
the lack of preparedness in the NHS to train clinical staff in telemedicine in terms of: demonstrating 
empathy, active listening, summarising and checking, formulating a shared management plan and 
provision of signposting, care and worsening advice (Patient 1250, lupus)








































































Figure 2. Views of telemedicine compared to F2F - Convenience and time 
0 10 20 30 40 50 60 70 80 90 100
Sufficient time - Clinician view                                                                                               
(MD = -0.49, P<0.001)
Sufficient time - Patient view
Convenience for clinicians - clinician view
Convenience for patients - Clinician view                                                                        
(MD = -0.37, P=0.001)
Convenience for patients - Patient view
Much worse Worse Same as F2F Better Much better
Fig 2a. Views on telemedicine compared to face to face - Convenience and time (N=1,340 patients, 
N=111 clinicians)
Note: T-tests comparing means of ratings from 1 (much worse) to 5 (much better) from clinicians and patients 
regarding views of telemedicine compared to F2F. MD = mean difference between scores of patients and 
clinicians assessed by t test.  If P>0.05 it is reported as non-significant
Fig 2b. Common clinician views of advantages and disadvantages of telemedicine for convenience
Category Advantages of telemedicine Disadvantages of telemedicine
Work/life 
balance
Able to work from home intermittently 
has lessened the stress of daily travel 
(Clinician 81, Nurse)
Inundated with emails from patients…yesterday 
spent 2 or 3 hours just dealing with patient 
emails. (Clinician 4, Consultant)
Time More efficient use of time for self and 
patient when they are in remission 
(Clinician 53, Nurse)
Sometimes we double see patients because 
we’re trying to deal with the problem on the 
telephone and then you end up trying to 
schedule them again to come in, and you’re 
talking about pressured waiting lists already 
(Clinician 1, Registrar)
Productivity Makes things easier for clinicians as we 
can more easily multi-task, check 
results…while speaking to the patient 
without having to make eye contact 
(Clinician 77, Registrar)
If you don’t answer then they keep calling…keep 
on being interrupted by all these phonecalls… 
then answering an email and then lots of calls 
that nobody is taking…interrupts me when 
maybe I’m maybe checking bloods and things 
can then go a bit wrong…it’s distractions all the 
time (Clinician 23, Consultant)
 
Theme 4: Barriers to safe and effective telemedicine
Although most clinicians acknowledged that problems had occurred with patient-initiated access 
during earlier stages of the pandemic, the majority felt that their own department/GP surgery was 








































































currently responding promptly. Several highlighted the importance of a quick response to patients 
experiencing flares: 
If a patient phones up a department, even if we’re working remotely, a lupus patient should be 
responded to on the same day, there’s no doubt about that (Clinician 25, Consultant)
A minority of patients reported that increased use of telemedicine had ensured quicker responses:
The GPs are much more efficient using telephone appointments and when I've needed them they've 
seemed much more responsive and engaged. The NHS has benefitted from changing how they work 
(Patient 890, Systemic sclerosis)
 However, emergency access remained highly variable and many patients felt ‘insecure’ due to 
continued difficulties in obtaining emergency care/advice. Overall patient medical security ratings 
(from 0 = totally medically abandoned to 100 = totally medically secure) were lower for patient 
recalled pre-pandemic levels (66.7) compared to during (48.1) the pandemic (mean difference 18.6, 
p<0.001). Differences between disease groups’ ratings of medical security increased during the 
pandemic. For example, recalled pre-pandemic medical security ratings were 68.9 for participants 
with inflammatory arthritis and 66.0 for participants with lupus (with a non-significant mean 
difference of 2.9, p=0.06). These had dropped to 51.8 (inflammatory arthritis) and 46.3 (lupus) in 
April 2021 (MD of 5.5, p=0.004). Medical security was lowest in Sjogren’s patients (42.2 in April 
2021).
Great difficulties in accessing support were frequently reported, sometimes from the departments 
that clinicians felt were responding promptly: 








































































Waiting for a call back after 4 voicemails…feel sad and scared knowing that when I really need 
medical help I have no-one (Patient 132, lupus)
Administrative staff triaging and ‘gate-keeping’ was particularly disliked; and there were reports of 
being made to feel ‘like I was making a fuss’ or being refused access, sometimes with life-
threatening consequences: 
You have to go through reception, she…didn’t think I should bother GP…  hung up on me…it was 3 or 
4 days that she agreed that actually a doctor did need to see me…my lovely GP who was like it’s too 
late, straight to A&E…kidney infection. I was in hospital for a week… If I had seen the GP in real life 
this would not have happened (Patient 9, lupus)
Perceptions of continued barriers to prompt care were also reflected in the quantitative findings, 
with for example only 48% being confident that a GP would respond within 24 hours, and only 55% 
confident that their rheumatology department would respond within 48 hours. Patients with 
inflammatory arthritis were significantly more confident (p=0.002) of getting a prompt response 
from their rheumatology department than those with lupus. Restricted methods of access were felt 
to disproportionately impact the most disadvantaged:
We’ve had some local Practices only allowing contact through econsult, so that means that if you 
can’t use it, you’re elderly, English not your first language, you’ve got learning difficulties… it’s not 
fair. They’re doing that whole barrier to protect their time (Clinician 7, GP)
Multiple barriers to safe and effective remote appointments were identified, with these barriers 
appearing to place certain groups at a disadvantage, particularly patients at an early stage of the 








































































disease journey. There were reports of greater diagnostic delays, less support at diagnosis, and less 
chance to build a supportive medical relationship with telemedicine than with face-to-face 
appointments: ‘With new patients it is really important to meet F2F and build up a rapport and 
confidence’ (Clinician 20, Nurse). These disadvantages were reflected statistically in that the newly 
diagnosed (<1 year) gave significantly lower ratings (p=0.009) for telemedicine (compared with face-
to-face) for relationship-building than those diagnosed >10 years ago.
Telemedicine was also reported by clinicians and patients to disadvantage (Table 3b): 
 Patients without English as a first language; those with hearing, cognitive or speech 
difficulties; or when the accent of the patient or clinician was felt to be difficult to 
understand.
 Patients with more complex, multi-system, potentially life-threatening diseases, particularly 
vasculitis or SLE. 
 Those in need of urgent care or with MH difficulties.
 Older patients; although the only statistically significant differences in views of telemedicine 
between age groups was in terms of convenience (a low negative correlation between age 
and convenience of -0.14, p=0.01). 
 Clinicians and patients experiencing difficulties with access to/ability with telemedicine 
related technology.
  Socio-economically or educationally disadvantaged patients.
Table 3a. Patient types/groups, some of whom expressed a preference for telemedicine 
Characteristic Example quote
Employed Telemedicine has been great for convenience as someone who works full time. F2F 
appointments in the NHS are frustrating as they are literally never on time. So have to 




I like the fact that if my condition is stable I don't have to waste 3 hours of my day to tell 
the consultant that. I have never felt rushed over the phone (Ppt 942, RA)
Experienced I know my disease and my body. My RA team know that if I say I'm ready for infusion 
they accept that (Ppt 1237, RA)













































































I also feel like it's more convenient as if I am having a bad fatigue day, I can still speak to 
someone whereas I may have had to cancel an in person slot. (Patient 97, mixed)
Table 3b. Patient and physician characteristics that may make telemedicine less 
acceptable/effective
Characteristic Example quote
Undiagnosed With my initial appointment first postponed and then moved to a phone call it took 
almost a whole year longer to be diagnosed, a whole year was lost without medication. I 
think for a first appointment this was terrible (Ppt 989, Inflammatory arthritis)
Newly 
diagnosed
GP telemedicine was difficult during early diagnosis as everything felt rushed and 
emotional support was lacking. I found my diagnosis very scary whilst trying to cope 
with a lot of pain and with very restricted mobility. This element was lost during a 
telephone appointment whereas at a face to face it would have been very apparent just 




I think a lot of us want to do more face to face in particular with something like 
lupus…For other diseases you just can look at the blood tests and do an adequate job 
but in something like lupus where blood tests don’t always correlate with symptoms and 
activity you’re then going on the only kind of assessment you can do on the telephone 
which is essentially doing it blind. (Clinician 24, Registrar)
Communication 
-Accents
Several of the Drs have accents that I find very hard to understand over the phone and 
as I have a slight hearing loss I find the experience frustrating and uncomfortable 
(Patient 16, Sjogrens) 
Elderly and/or 
deaf
All telemedicine is hard for the elderly.  I am very deaf and even with two hearing aids 




My hearing isn't the best and it's much easier face-to-face.  I like to have my wife with 
me to corroborate and amplify and remind me if forget anything which is difficult on the 





My younger colleagues…they are much better than me at managing online and 
connection… I end up making the mistakes…a lot of time wasted in trying to get these 




In terms of support and living in stressful, over-crowded environments…won’t get what 
they need or learn easily from a remote consultation…need more support because 
there’s less support at home and they have less background knowledge (Clinician 2, 
Consultant)
Theme 5: Cost-cutting, clinical need or choice?
Although there was an overall preference for face-to-face appointments, most participants 
supported a mixture of face-to-face and telemedicine (Figure 3a). A significantly (p<0.01) higher 
proportion of clinicians (70%) than patients (46%) wanted all emergency appointments to be face-to-
face. This disparity may be partially explained by clinicians being very concerned about the 
difficulties of diagnosing and treating a flare remotely, including medico-legal considerations, whilst 








































































patients appreciated the option of telemedicine if feeling too unwell to physically attend.  There 
were no significant differences in patient preference between the mode of telemedicine (phone or 
video), or between disease groups, in views of telemedicine’s acceptability. Clinicians had a strong 
preference (over twice as many) for telephone appointments over videocalls (Fig 3b). Male clinicians 
and rheumatology registrars were the most negative clinician sub-groups on the relative merits of 
telemedicine over face-to-face both quantitively and qualitatively, and rheumatology nurses were 
the most positive.  
Concerns were expressed that telemedicine would be over-used by the NHS and hospital 
management (Fig3a, 3c) as a cost and time-saving measure rather than in patients’ best interests. 
Clinicians (only 3% of whom felt telemedicine overall was better than face-to-face) and patients had 
rarely been consulted as to their preferences:
We’ve got a top-down system where the view on consultation has been taken at a different level 
than purely a clinical one (Clinician 1, Registrar)



























All telemedicine Mostly telemedicine 50/50 Mostly F2F All F2F
Fig 3a. Preferences for proportion of appointments between telemedicine and F2F 
(N=1,337 patients, N=111 clinicians)
Note: Hospital management preferences are as reported by clinicians








































































Patient preferences for 
type of telemedicine









Either - no preference Neither - dislike both
Fig 3b. Preferences for mode of telemedicine 
delivery  (N=1,340 patients, N=111 clinicians)
The importance of assessing individual suitability, for example by pre-consultation questionnaires, 
and allowing clinician and patient choice, were frequently highlighted: 
The rapid digitalisation and use of telemedicine must stay but appropriate patient selection is key, it 
is perfect for some but disastrous for others (Clinician 40, Consultant)
Discussion
This is the first mixed methods telemedicine study we are aware of that compares the views of 
rheumatology patients, rheumatology clinicians and GPs. The findings identified a place for 
telemedicine for certain patients, yet a strong overall preference for face-to-face consultations on 
the part of both clinicians and patients. Telemedicine was widely perceived to reduce the accuracy 
of assessments and to impede the building of trusting medical relationships. Consistent with other 
studies16, our study indicated that telemedicine was particularly unsuitable for initial 
rheumatological diagnoses. Contributing factors to the inaccurate assessments and multiple 
misdiagnoses reported with telemedicine included: no examinations, limited testing, increased 
Fig 3c. Example quotes of clinicians’ conflicting views with 
management
I fear that the pandemic will be used to usher in unproven 
and potentially harmful, but fashionable, changes to 
practice. There will be some benefits to remote medicine but 
I fear there hasn’t been a serious attempt to think of which 
clinical situations it is most useful in (Clinician 56, 
Consultant)
I have a feeling that hospitals will insist on more 
telemedicine reviews rather than F2F to save money…most 
patients will hate it (Clinician 65, Nurse)
I feel that management think that equally good care is 
possible via telemedicine which it is not. The doctor as drug 
doesn’t work as well over the phone (Clinician 108, 
Consultant)








































































patient reticence to report symptoms, and increased clinician difficulty in eliciting and identifying 
unspoken concerns without non-verbal cues. The importance of non-verbal communication in 
medical relationships has been widely reported23,24,25, including eye-contact26, expressive (to 
reassure or comfort) touch27 and smiling28. In agreement with other studies29 this lack of non-verbal 
interaction was found to be particularly detrimental to the eliciting and reporting of mental health 
concerns, although a minority of our participants (both clinician and patient) found it easier to 
discuss mental health and sensitive issues remotely. Demonstrations of listening and empathy, 
identified as of key importance to rheumatology patients in terms of satisfaction and 
behaviours30,31,32, were perceived by our participants to be limited with telemedicine.  This is in 
contrast to another study reporting very few (<10%) clinicians and patients felt tele-rheumatology 
had a negative impact on the medical relationship33. 
Our study participants were mainly UK-based (96%), where telemedicine to-date has been reported 
as often being the substitution of a face-to-face appointment for a telephone-call34, or less 
frequently a video-call. This may partially explain why our findings were more negative towards 
telemedicine than studies on medical systems which utilize more visual telemedicine and/or 
integration of multiple remote methods of assessing and supporting patients35,36. Indeed Leggett at 
al found a much higher level of diagnostic accuracy and satisfaction with video compared to 
telephone consultations37. Although interestingly our rheumatology clinicians had a strong 
preference for telephone over video consultations, possibly influenced by technology constraints 
and familiarity, and patient preferences were equally divided. 
The benefits of digital technology and integrated systems allowing prompt access to health data and 
communication between patients and clinicians across multiple disciplines and NHS trusts have yet 
to be realised in many areas. This is a source of inefficiency and frustration currently in the UK38, and 
addressing it would greatly improve patient empowerment, satisfaction and self-management. 








































































Greater use of patient-initiated follow-up (PIFU)39 may also reduce existing inefficiencies and sub-
optimal care from the current dominant model of reviewing rheumatology patients according to 
timescales rather than disease activity. However, this study has demonstrated that a move towards 
further PIFU urgently requires improved administrative systems in some rheumatology departments 
to ensure a prompt, appropriate response to the vast increase in patient-initiated contact.  This is 
currently generating difficulties in managing work-life balance for some clinicians, and endangering 
and upsetting the many patients who report being unable to access care when required, as also 
found in studies at earlier stages of the pandemic40,41. Our results indicate that telemedicine may 
have increased existing barriers to accessing medical support42, such as inappropriate telephone 
triaging, and difficulties navigating administrative and reception systems43. The importance of 
prompt accessibility in a flare identified in our previous study38 was repeatedly reiterated by senior 
rheumatologists in this study, as delays can cause permanent organ/joint damage and be fatal in the 
more severe cases9. 
We found no differences in preferences for telemedicine between disease groups. However, our 
participants with inflammatory arthritis had significantly higher confidence in a prompt response 
from their rheumatology department, higher ratings for medical security, and lower reductions in 
medical security during the pandemic, than patients with lupus or other rare autoimmune rheumatic 
diseases, such as Sjogren’s. This adds credence to the clinician participants’ and authors’ concerns 
that there are inequalities in care between rare and more common rheumatic diseases, and that 
telemedicine may increase these, and other inequalities. It is particularly important that proactive 
efforts44 through policy ensure telemedicine does not increase existing health inequalities45 and 
further disadvantage groups, such as the elderly and those with communication challenges.
Aside from the obvious benefits of telemedicine reducing the risks of infection, additional benefits 
were identified. With a patient population often suffering from pain and fatigue31,46,47, and long 








































































journeys to hospital, especially for tertiary care, the option of a telemedicine appointment was felt 
to be equally/more acceptable in some cases. This included for medication reviews or administrative 
queries, and for stable patients who are knowledgeable, and secure in their pre-existing medical 
relationship(s). As previous studies also advise, individual choice16 and careful patient selection for 
telemedicine will be essential to ensure safety and acceptability, and to alleviate concerns that 
telemedicine in the NHS is being instituted primarily as a cost and time-saving measure. 
It is important to emphasise that our study patients all had autoimmune inflammatory rheumatic 
diseases and these patients often have more severe and/or unpredictable disease that may be less 
suited to telemedicine. A limitation of this study is that those with technological, communication or 
socio-economic barriers to accessing telemedicine are also less likely to participate in an online 
survey. This study’s great strength was in eliciting multiple viewpoints from all sides of patient-
clinician relationships, including patients with a variety of rheumatological diseases. This, and 
combining of qualitative and quantitative data at each stage of the research, allowed for 
triangulation and helped address threats to validity and reliability. The many studies reporting 
authors’ own patients’ high levels of satisfaction should be viewed with some caution due to the 
power differential and high-risk of social desirability bias. Further strengths and limitations are 
summarised in Supplementary Data S1, available at Rheumatology online.
It is probable that some of the negative perceptions of telemedicine, particularly relating to some 
access barriers and clinicians having less time, are partly influenced by ongoing Covid-19 pressure 
and the huge backlog of rheumatology patients requiring appointments, rather than telemedicine 
itself. Concerns and risks may lessen as remote consultation systems are improved, and the 
identified benefits for select patients are realised. However, it is unlikely that the serious concerns 
expressed by our participants regarding assessing complex rheumatological conditions remotely will 
be fully resolvable.  This has implications for the telemedicine ambitions and plans of the UK and 








































































other health systems, and highlights the need for ongoing assessment and mitigation of the clinical 
risks associated with a telemedicine strategy.  
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